<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>The Roslin Institute</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/45B93CB0-CE6C-4A23-A17F-DBF5536D9837"><gtr:id>45B93CB0-CE6C-4A23-A17F-DBF5536D9837</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Freeman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/797E2C6C-9AB7-4CA3-936E-4F90E749482C"><gtr:id>797E2C6C-9AB7-4CA3-936E-4F90E749482C</gtr:id><gtr:firstName>Anton</gtr:firstName><gtr:otherNames>James</gtr:otherNames><gtr:surname>Enright</gtr:surname><gtr:orcidId>0000-0002-6090-3100</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/25E456AA-19CB-42DC-AB77-08DC4CB2FD3A"><gtr:id>25E456AA-19CB-42DC-AB77-08DC4CB2FD3A</gtr:id><gtr:firstName>Athanasios</gtr:firstName><gtr:surname>Theocharidis</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FI001107%2F1"><gtr:id>99D085DB-1E0A-4FC1-B983-69956A503D32</gtr:id><gtr:title>BioLayout Express3D: A Community Resource for the Network Visualisation and Analysis of Biological Data and Pathways</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/I001107/1</gtr:grantReference><gtr:abstractText>Biological data is increasingly complex and large-scale. Genome sequencing and other high-throughput technologies have provided us with a parts-list of life, together with a wealth of information about how these components interact with each other. Humans are inherently visual and representing this information in the form of graphs and graphics is an extremely useful aid to our understanding of its innate complexity. Tools that assist biologists in their ability to visualise, analyse and interpret biological systems are therefore potentially of great utility. Both applicants have a long-standing interest in the analysis of biological data and have been involved in the development of computer programs for its visualisation and analysis. In particular, with support from the BBSRC and Wellcome Trust, we have co-developed a powerful network analysis tool, BioLayout Express3D. This software has proved highly useful to applicant's research and also popular with the wider academic community. We therefore seek to continue to expand its functionality into new areas, thereby maintaining its position at the cutting-edge of the visualisation and interpretation of biological systems. This project capitalises on the existing collaborative work and aims to explore new areas of computation, biology and visualisation with both participating laboratories scoping, testing and validating developments prior to their release to the wider community. Our first aim is to refine and expand the existing interface of BioLayout Express3D to enable it to read and process biological data from a wide variety of sources. We also seek to improve the quality of the user interface and its analytical potential, as well as to provide improved support and training its users. Secondly we aim to develop its capabilities to be deployed for the visualisation and analysis of data derived from other sources e.g. EBI databases, and for providing access to networks of analysed data. Thirdly, we wish to further explore the potential to use this tool for the modelling and visualisation of biological pathways. Finally, with the rapid pace of development of programming languages and advanced computer hardware, we will explore the potential to harness the power these developments for improving the power and speed of network analyses. We believe that the proposed project will allow us to deliver a cutting-edge tool addressing the shortcomings of currently available commercial and academic systems. The rapid growth of 3D graphics hardware and computer speed allows us to develop these tools for regular desktop computers, yet still allow the analysis of datasets an order of magnitude larger than other systems. BioLayout Express3D will allow biologists to contextualise and visualise their data in an unprecedented manner and we hope it will be a significant boon to the wider academic community.</gtr:abstractText><gtr:technicalSummary>The availability of complete genome sequences and technologies that allow us to characterise the activity of the genes they encode, protein interaction partners and pathways has greatly contributed to our appreciation of biological systems. However, in order to understand the large amounts of data generated by these functional genomics and proteomics platforms and the complexity of biological systems, there has been increasing emphasis on developing new methods and tools in computational and systems biology, to allow for the comprehensive mapping of cellular and molecular networks. However, one of the main difficulties we currently face is how best to integrate and visualise these disparate data types and use the information to better understand biological systems in health and disease. Over the last few years we have developed the successful BioLayout Express3D application with support from the BBSRC and Wellcome Trust. We now seek funding to maintain this software at the cutting-edge of this field and to explore new areas of analysis and biology. We intend to expand and develop the basic interface to include parsing of most common biological datasets, such as networks and pathways from the standard exchange formats, as well as its built-in analytical capabilities. We also seek to expand the paradigm of network visualisation to capture both the spatial and temporal arrangements of genes, proteins and other molecules. Utilising the applicant's expertise in the analysis genomics data, we will further develop the application for the visualisation and interpretation of complex biological datasets in an intuitive and fast 3-Dimensional interface. In so doing we will support others in the deployment and use of the tool.</gtr:technicalSummary><gtr:potentialImpactText>With the recent advent and accessibility of low cost, high throughput omics analysis platforms many are now employing these technologies for their field of interest. As a result, researchers whose interests may have traditionally been focused on one or a small number of biological components are now often faced with analysing enormous amounts of data pertaining to the activity of many thousands of genes and proteins and their interactions in the cell. Large datasets are inevitably complex and many aspects of data analysis remain frustrating, even for those skilled in the art. Indeed, despite a plethora of analytical and statistical approaches to deal with 'omics data, the analysis of large datasets still presents a significant challenge and as a result much of the potential value of omics data is frequently never realised. BioLayout Express3D has been developed as a stand alone application, primarily for the visualisation and analysis of large network graphs. It was originally developed to provide an improved method for visualisation and analysis of microarray gene expression data. Using this tool we have been able explore a number of large and complicated datasets in a way not possible by conventional analytical techniques. It has facilitated the acquisition of new insights into the nature of complex data derived from complex diseases and allowed us to identify potential biomarkers and therapeutic targets of disease. Future developments to the tool will also allow us to support the analysis of other data types and in so doing potentially allow improved interpretation of these data. In our opinion BioLayout Express3D is now the most advanced tool available in the commercial or academic domains for the rendering and analysis of large network graphs derived not only from omics data but in principle relationships between any entities or concepts. It has an extensive range of built in tools to enable the user to modify the visual characteristics of the networks, select nodes, view their identity and associated data, and to perform sophisticated analyses of network topology. It has also been designed to be easy to use by others and to work on all standard computational platforms. To this end we have already gone to considerable lengths to support others in its deployment and use through the development of a comprehensive website and publication of a detail protocol. The current application will allow us to further improve the functionality of BioLayout Express3D and support its growing user base across different academic communities with improved training opportunities and online support. In so doing, we hope its analytical capabilities will allow others to capitalise on their often considerable investment in data generation and help drive their work forward. It also perhaps worthy of mention that over the last year 21% of hits on the website were recorded as coming from commercial organisations perhaps reflecting the potential application of this type of analyses in commercial domain.</gtr:potentialImpactText><gtr:fund><gtr:end>2013-11-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>348540</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits - Prestonfield primary school, Edinburgh</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>36429ACB-D5C4-47DA-96FB-66587FD10788</gtr:id><gtr:impact>Talk to P4 and P5 classes about biological research, especially around DNA as part of work week. Showed BioLayout and lots of questions asked by pupils.

I was told by the teacher that after my talks some of children said they wanted to be scientists.</gtr:impact><gtr:outcomeId>545fe28372cc54.95595701</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Makers faire</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>55D713AD-5B03-44F1-8A3D-4B1EE1D08D98</gtr:id><gtr:impact>Presented BioLayout and how we are using the tool. Generated a lot on public interest.

Good feedback on the day.</gtr:impact><gtr:outcomeId>54639208845e29.98792384</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.life.org.uk/whats-on/maker-faire-uk-2014#.VGOR9vmsVBm</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The release of this tool as open-source software allows others in the academic community and beyond make use of its unique analytical capabilities for their own research. The numbers of scientists using this program worldwide is increasing (currently the program is being used 3,000-4,000 times per month) and there are a growing list of publications where the tool has been employed.

More recently a company Kajeka Ltd. www.kajeka.com has been founded to exploit this technology in the bioscience sector and beyond.</gtr:description><gtr:id>889FE4E6-CE4A-4E15-B641-0A9218D6D2DA</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>m-4894193126.721488de280656</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>This is a network analysis tool and represents the product of over 15 years research and development. It uses a combination of high end 3D graphics, algorithms and user-friendly graphical interfaces to allow the user to explore and better analyse their data.</gtr:description><gtr:grantRef>BB/I001107/1</gtr:grantRef><gtr:id>6E87D558-AB48-4978-9BEE-754000C39815</gtr:id><gtr:impact>The website currently receives hits from approx. 700 users a month from around the globe and is used 1500-2000 times a month. This tool has been used in analyses that have contributed to over 40 publications. The technology and know how developed is currently en route to being commercialised and developed further by a new spin out company called Kajeka.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>546295dd2bbbe9.12622324</gtr:outcomeId><gtr:protection>Copyrighted (e.g. software)</gtr:protection><gtr:title>BioLayout Express3D</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>BioLayout Express3D is a tool designed for the rapid discovery of patterns and interactions within what is often called big data. In biology there is a vast amount of this data being generated by modern analysis platforms and this tool allows users to gain insights from it.</gtr:description><gtr:exploitationPathways>We provide a powerful tool for use of others in their research endeavours. There is a growing number of publications that have used BioLayout not only from our group but also from others. More still are beginning to change over to the newer commercial version of this tool called Miru, sold by Kajeka Ltd a company originally set up to capitalise on the BioLayout IP and develop new network analysis tools for use in other sectors.</gtr:exploitationPathways><gtr:id>96842965-F56D-4C1A-BEB8-EFE41E1649BE</gtr:id><gtr:outcomeId>5460b374d83111.94780785</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.biolayout.org/about/publications/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>BioLayout Express3D is a powerful tool for the visualization and analysis of network graphs. Network-based approaches are becoming increasingly popular for the analysis of complex systems of interaction and high dimensional data. Networks can be produced from a wide variety of relationships between entities. In biology this includes the interactions between individuals, disease transmission, sequence similarity, metabolic pathways, protein interactions, pathways, regulatory cascades, gene expression, clinical data. 

This tool represents the product of over 15 years research and development and uses a combination of high end 3D graphics, algorithms and user-friendly graphical interfaces to allow the user to explore and better analyse their data.</gtr:description><gtr:id>2FF00C3A-AB6B-48BC-B1DA-95983182D98C</gtr:id><gtr:impact>The website currently receives hits from approx. 700 users a month from around the globe and is used 1500-2000 times a month. This tool has been used in analyses that have contributed to over 40 publications. The technology and know how developed is currently en route to being commercialised and developed further by a new spin out company called Kajeka.</gtr:impact><gtr:outcomeId>546294dc9c00b2.01176261</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>BioLayout Express3D</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://www.biolayout.org/</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Virtually Immune is a resource that aims to support the graphical and computational modelling of immune pathways. The tools and resources presented there are primarily designed for biologists, both to use and to allow them to develop their own models of systems of interest to them.

Virtually Immune introduces:
a standardised system for presenting pathway knowledge
a user-friendly platform for modelling
pathway resources which capture and collate information from hundreds of papers
a platform for knowledge exchange within the scientific community</gtr:description><gtr:id>09A289BB-4AF4-41AA-BC71-7452F2A2948F</gtr:id><gtr:impact>As a result of setting up this website as part of the phase 1 of the NCR's Crack it challenge we are beginning to guide people to it as a resource for our modelling efforts. Two papers in preparation describing the tools and our modelling approach.</gtr:impact><gtr:outcomeId>545fe3b2f3cfe1.12202968</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Virtually Immune</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:url>http://www.virtuallyimmune.org/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Macrophages.com is an online resource for those interested in macrophages and their role as major effector cells in innate and adaptive immunity. This website is designed to act as a centralised resource for the worldwide community of scientists interested in different aspects of macrophage biology. Included here are:
 
Collections of macrophage images in different tissues
Expression datasets and transcriptional analyses
Analysis of protein expression in macrophages
A gene-centered information portal for macrophage-expressed genes
Macrophage pathway resources
Curated key publications and reviews on aspects of macrophage biology
Useful online resources
News and events</gtr:description><gtr:id>491B4775-E213-427D-A17C-4E544BE179BB</gtr:id><gtr:impact>This site is currently receiving hits from over a 1,00 unique users per week.</gtr:impact><gtr:outcomeId>545d09235d23b6.01011440</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>macrophages.com</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.macrophages.com/</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs><gtr:softwareAndTechnicalProductOutput><gtr:description>BioLayout Express3D is a powerful tool for the visualization and analysis of network graphs. Network-based approaches are becoming increasingly popular for the analysis of complex systems of interaction and high dimensional data. Networks can be produced from a wide variety of relationships between entities. In biology this includes the interactions between individuals, disease transmission, sequence similarity, metabolic pathways, protein interactions, pathways, regulatory cascades, gene expression, clinical data. 

This tool represents the product of over 15 years research and development and uses a combination of high end 3D graphics, algorithms and user-friendly graphical interfaces to allow the user to explore and better analyse their data.</gtr:description><gtr:id>8FCB8CAE-8082-47B5-8446-19153510C2EB</gtr:id><gtr:impact>The website currently receives hits from approx. 700 users a month from around the globe and is used 1500-2000 times a month. This tool has been used in analyses that have contributed to over 40 publications.</gtr:impact><gtr:outcomeId>545fe0a0be0737.66671631</gtr:outcomeId><gtr:title>BioLayout Express3D</gtr:title><gtr:type>Software</gtr:type><gtr:url>http://www.biolayout.org/</gtr:url><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:softwareAndTechnicalProductOutput></gtr:softwareAndTechnicalProductOutputs><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>Fios Genomics Ltd</gtr:companyName><gtr:description>Fios Genomics is a provider of an extensive range of bioinformatics data analysis services to Pharma, CROs and academia for drug discovery &amp;amp; development and applied research across all species.

They provide access to a combined resource of in-house bioinformaticians, statisticians and biologists working together to analyse and interpret your genomic, transcriptomic and proteomic data.</gtr:description><gtr:id>DE003C91-224C-4E8D-8010-4789357401A6</gtr:id><gtr:impact>Supply of data analysis services to pharma, CRO's and academic groups. Currently employ 7 full time people.</gtr:impact><gtr:outcomeId>545fdda0135da1.77421524</gtr:outcomeId><gtr:url>http://www.fiosgenomics.com</gtr:url><gtr:yearCompanyFormed>2008</gtr:yearCompanyFormed></gtr:spinOutOutput><gtr:spinOutOutput><gtr:companyName>Kajeka Ltd</gtr:companyName><gtr:description>Company offering network analysis tools and services for the analysis of high dimensional data. Based on IP and know how behind BioLayout Express3D. We are also generating a new generation of network analysis tools for enterprise level clients based on dynamic graph rendering. The company has won a number of grants to aid its development and is now actively seeking investment.</gtr:description><gtr:id>78B6BCB4-14AD-4074-8674-C2BBFBA55915</gtr:id><gtr:impact>The company is still at an early stage in its development but is beginning to gain traction and clients for the software. We are also collaborating with academic computer science groups in Newcastle and Birmingham who develop network analysis algorithms who interested in the company's network visualization capabilities.</gtr:impact><gtr:outcomeId>545fdea0174cf8.68967572</gtr:outcomeId><gtr:url>http://www.kajeka.com</gtr:url><gtr:yearCompanyFormed>2014</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>98BE4E45-7EE8-4A39-A952-F1B6C7838120</gtr:id><gtr:title>A promoter-level mammalian expression atlas.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/323e91786338ef638749450b9312e13a"><gtr:id>323e91786338ef638749450b9312e13a</gtr:id><gtr:otherNames>FANTOM Consortium and the RIKEN PMI and CLST (DGT)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545d071a571df6.74328195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD3C2294-E597-48EE-A3F3-20EEAE35EB3B</gtr:id><gtr:title>Construction, visualisation, and clustering of transcription networks from microarray expression data.</gtr:title><gtr:parentPublicationTitle>PLoS computational biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec4b46deb7139726b4d65620417ac21d"><gtr:id>ec4b46deb7139726b4d65620417ac21d</gtr:id><gtr:otherNames>Freeman TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1553-734X</gtr:issn><gtr:outcomeId>doi_55f93c93c03775f6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22EB50ED-A615-45E9-B08D-2A3A7F46E3F1</gtr:id><gtr:title>Derivation of marker gene signatures from human skin and their use in the interpretation of the transcriptional changes associated with dermatological disorders.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32614cfc26d8cc5e23d32e19cf70373a"><gtr:id>32614cfc26d8cc5e23d32e19cf70373a</gtr:id><gtr:otherNames>Shih BB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>58c2aee1ef89e3.65881115</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2921C53A-6AB3-47F3-9AEA-C4A838FEC279</gtr:id><gtr:title>Modelling the Structure and Dynamics of Biological Pathways.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e4e8423698f87c88bbeb725b057f3cf"><gtr:id>9e4e8423698f87c88bbeb725b057f3cf</gtr:id><gtr:otherNames>O'Hara L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>585d3d9fb1d496.32287131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80E61D5D-E611-40F3-BF16-11378E0AFDA8</gtr:id><gtr:title>Functional clustering and lineage markers: insights into cellular differentiation and gene function from large-scale microarray studies of purified primary cell populations.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33a19c5b757d89036ac7d90155855752"><gtr:id>33a19c5b757d89036ac7d90155855752</gtr:id><gtr:otherNames>Hume DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>545d071759cad8.25699226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1835E9A6-00C5-493A-AF48-C99B623F51D8</gtr:id><gtr:title>Meta-analysis of lineage-specific gene expression signatures in mouse leukocyte populations.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>doi_55f93b93bff00a3f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138098F4-D883-4C1E-AF20-BE861348D311</gtr:id><gtr:title>Assembly of a Parts List of the Human Mitotic Cell Cycle Machinery</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89bb1399543ace39235d36321731a1a6"><gtr:id>89bb1399543ace39235d36321731a1a6</gtr:id><gtr:otherNames>Giotti B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa64ed6184124.89921807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17D4D616-B3F0-404A-9C98-85AC8976D258</gtr:id><gtr:title>Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>doi_55f93c93c0183d78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35C32D53-9463-4EE8-B4F2-EF31D964A9A4</gtr:id><gtr:title>The impact of breed and tissue compartment on the response of pig macrophages to lipopolysaccharide.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d1bda788f1228639381286d7eec1132"><gtr:id>9d1bda788f1228639381286d7eec1132</gtr:id><gtr:otherNames>Kapetanovic R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545d0719d3bda2.34971722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E74F9308-432D-4881-B926-4081D9AAEBC2</gtr:id><gtr:title>Co-expression of FBN1 with mesenchyme-specific genes in mouse cell lines: implications for phenotypic variability in Marfan syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/086c17007ac90283d8373484cc1e7c4f"><gtr:id>086c17007ac90283d8373484cc1e7c4f</gtr:id><gtr:otherNames>Summers KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>545d0509a787f8.77222815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB29D178-82D8-4249-BE90-F6A8D9CD7E10</gtr:id><gtr:title>Distribution of Misfolded Prion Protein Seeding Activity Alone Does Not Predict Regions of Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>PLoS biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/928f2d4cba1389640d2b6f4708ac0805"><gtr:id>928f2d4cba1389640d2b6f4708ac0805</gtr:id><gtr:otherNames>Alibhai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1544-9173</gtr:issn><gtr:outcomeId>58c2aee26931e8.31913129</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5AED2059-0D87-43F2-B988-1EB1185A3E75</gtr:id><gtr:title>Reciprocal regulation of lymphoid tissue development in the large intestine by IL-25 and IL-23.</gtr:title><gtr:parentPublicationTitle>Mucosal immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4ae76722b706ebf7ff076cff357a4c5"><gtr:id>c4ae76722b706ebf7ff076cff357a4c5</gtr:id><gtr:otherNames>Donaldson DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1933-0219</gtr:issn><gtr:outcomeId>doi_55f93c93c003b888</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD8E3A49-4C7D-4236-AC2B-A295268A92CD</gtr:id><gtr:title>Meta-analysis reveals conserved cell cycle transcriptional network across multiple human cell types.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89bb1399543ace39235d36321731a1a6"><gtr:id>89bb1399543ace39235d36321731a1a6</gtr:id><gtr:otherNames>Giotti B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>58c2aee230edd8.96424553</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF2F83F5-FD3B-4E38-A2B9-2C2FBE1941A3</gtr:id><gtr:title>Combined genome-wide expression profiling and targeted RNA interference in primary mouse macrophages reveals perturbation of transcriptional networks associated with interferon signalling.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dbc4e659dac66e767c905a87d3420fb7"><gtr:id>dbc4e659dac66e767c905a87d3420fb7</gtr:id><gtr:otherNames>Lacaze P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545d0716dd78f3.21906750</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD03EF6D-D315-4088-AD32-BF115617B45B</gtr:id><gtr:title>Can DCs be distinguished from macrophages by molecular signatures?</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33a19c5b757d89036ac7d90155855752"><gtr:id>33a19c5b757d89036ac7d90155855752</gtr:id><gtr:otherNames>Hume DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>545d0719863818.45333026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A961F525-2D77-4838-9B3F-EBC7F569960A</gtr:id><gtr:title>Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection.</gtr:title><gtr:parentPublicationTitle>Infection and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1bb99143189ce9b842790ff92e34e64"><gtr:id>d1bb99143189ce9b842790ff92e34e64</gtr:id><gtr:otherNames>Natividad A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0019-9567</gtr:issn><gtr:outcomeId>545d0717ebb751.70733273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19C4F13A-6CAB-4247-BEF6-47E296633965</gtr:id><gtr:title>Network visualization and analysis of gene expression data using BioLayout Express(3D).</gtr:title><gtr:parentPublicationTitle>Nature protocols</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1ea7c02199af45c78637b846dec495"><gtr:id>ff1ea7c02199af45c78637b846dec495</gtr:id><gtr:otherNames>Theocharidis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1750-2799</gtr:issn><gtr:outcomeId>545d05097e04d6.72174589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DE09D34-4E60-425E-ACC7-236D057DEA94</gtr:id><gtr:title>Visualisation of BioPAX Networks using BioLayout Express (3D).</gtr:title><gtr:parentPublicationTitle>F1000Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85cf1456f912c76773a5d57e73d7fe82"><gtr:id>85cf1456f912c76773a5d57e73d7fe82</gtr:id><gtr:otherNames>Wright DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2046-1402</gtr:issn><gtr:outcomeId>doi_55f93c93c021b80a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>659D8102-8839-405C-94C8-300E6708B01B</gtr:id><gtr:title>Construction of a large scale integrated map of macrophage pathogen recognition and effector systems.</gtr:title><gtr:parentPublicationTitle>BMC systems biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0630e40ace960faa3401e59b48ba350"><gtr:id>e0630e40ace960faa3401e59b48ba350</gtr:id><gtr:otherNames>Raza S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1752-0509</gtr:issn><gtr:outcomeId>545d07177cc022.51294922</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6EC766A-DB4D-4B57-9EAC-2E745E26B1B9</gtr:id><gtr:title>Coexpression analysis of large cancer datasets provides insight into the cellular phenotypes of the tumour microenvironment.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/088b80879ab20a1cb8228e4d4233f85d"><gtr:id>088b80879ab20a1cb8228e4d4233f85d</gtr:id><gtr:otherNames>Doig TN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545d0719ab4f35.26260053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9016A62-3C66-47FD-A67F-58470B78749E</gtr:id><gtr:title>Macrophages.com: an on-line community resource for innate immunity research.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee0ce9f1fa3681a2efd00e445cc6b6ba"><gtr:id>ee0ce9f1fa3681a2efd00e445cc6b6ba</gtr:id><gtr:otherNames>Robert C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>doi_55f93b93bff8fb6b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F2CF45-AF56-4788-8468-6825BEDDB88A</gtr:id><gtr:title>A gene expression atlas of the domestic pig.</gtr:title><gtr:parentPublicationTitle>BMC biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec4b46deb7139726b4d65620417ac21d"><gtr:id>ec4b46deb7139726b4d65620417ac21d</gtr:id><gtr:otherNames>Freeman TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1741-7007</gtr:issn><gtr:outcomeId>545d0719615401.71513722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1812C9FF-1E1D-487C-BD1F-7B02782EB17E</gtr:id><gtr:title>Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65283d7736c7a6032735ed8ca746c900"><gtr:id>65283d7736c7a6032735ed8ca746c900</gtr:id><gtr:otherNames>Xue J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>545d071a306869.60501831</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2EC44DD-718A-4803-B8AF-CE99187C61C8</gtr:id><gtr:title>An expression atlas of human primary cells: inference of gene function from coexpression networks.</gtr:title><gtr:parentPublicationTitle>BMC genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2164</gtr:issn><gtr:outcomeId>545d050a6de602.26838025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9DA3414-59CD-40E7-A4AD-7810079162D4</gtr:id><gtr:title>Analysis of the transcriptional networks underpinning the activation of murine macrophages by inflammatory mediators.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e0630e40ace960faa3401e59b48ba350"><gtr:id>e0630e40ace960faa3401e59b48ba350</gtr:id><gtr:otherNames>Raza S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn><gtr:outcomeId>545d071a7d2424.12518848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8AF0A882-8C9C-468F-BF91-9432C361C9E1</gtr:id><gtr:title>The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitions.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bef34b127e06d8920628e7c46ea5a3e"><gtr:id>7bef34b127e06d8920628e7c46ea5a3e</gtr:id><gtr:otherNames>Letek M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>545d07181d1343.75575769</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BBDD308-E99A-45EB-8307-9DE251A40C58</gtr:id><gtr:title>Bovine Host Genetic Variation Influences Rumen Microbial Methane Production with Best Selection Criterion for Low Methane Emitting and Efficiently Feed Converting Hosts Based on Metagenomic Gene Abundance.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a89f8eaef4264ea6e1fd5f8b220b084"><gtr:id>9a89f8eaef4264ea6e1fd5f8b220b084</gtr:id><gtr:otherNames>Roehe R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>58c2b02307b7b9.21706916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6A8C3A5-0262-42EA-9147-302BCCAE78EC</gtr:id><gtr:title>Transcriptomic analysis of mononuclear phagocyte differentiation and activation.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33a19c5b757d89036ac7d90155855752"><gtr:id>33a19c5b757d89036ac7d90155855752</gtr:id><gtr:otherNames>Hume DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>545d071b04bda7.84258209</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>855D9DEE-5C3E-4285-BEAB-030C3ED62CF6</gtr:id><gtr:title>Microglial brain region-dependent diversity and selective regional sensitivities to aging.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e6ae7d58b3f47002ea4e3da59ba8c46"><gtr:id>8e6ae7d58b3f47002ea4e3da59ba8c46</gtr:id><gtr:otherNames>Grabert K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>58c2b0235c1519.00100442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA561BF9-A519-4E75-9484-48293D913717</gtr:id><gtr:title>Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e413a1710ec827e70fa6d550dceb480"><gtr:id>8e413a1710ec827e70fa6d550dceb480</gtr:id><gtr:otherNames>Leday GGR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>5a9ec1661ebd29.74841237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B72A49C8-54D8-40AE-9BD5-85FD37505779</gtr:id><gtr:title>Modulation of macrophage antitumor potential by apoptotic lymphoma cells.</gtr:title><gtr:parentPublicationTitle>Cell death and differentiation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48887c41dbf20f46e5371dbd32867463"><gtr:id>48887c41dbf20f46e5371dbd32867463</gtr:id><gtr:otherNames>Voss JJLP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1350-9047</gtr:issn><gtr:outcomeId>58c2aee2a93eb7.37261141</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FBD6F82-9BAE-446B-B69B-0D98012EF415</gtr:id><gtr:title>Gateways to the FANTOM5 promoter level mammalian expression atlas.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf199d738fd64a955cfeb3e7c9c2657b"><gtr:id>cf199d738fd64a955cfeb3e7c9c2657b</gtr:id><gtr:otherNames>Lizio M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>5675e02bb60c2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B26C390A-438A-496A-917A-9F20AE5F98F7</gtr:id><gtr:title>Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08dad7e596adc2ade3abde553f88575e"><gtr:id>08dad7e596adc2ade3abde553f88575e</gtr:id><gtr:otherNames>Polak ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a73279aeaf049.56913203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>242BA1BE-6D9E-4816-8924-3E19102CCAAE</gtr:id><gtr:title>Reprogramming pig fetal fibroblasts reveals a functional LIF signaling pathway.</gtr:title><gtr:parentPublicationTitle>Cellular reprogramming</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c9034d35a081ce1352b0c0da37d0a5f"><gtr:id>4c9034d35a081ce1352b0c0da37d0a5f</gtr:id><gtr:otherNames>Thomson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2152-4971</gtr:issn><gtr:outcomeId>545d0718e0cc47.50788663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9FC94FD-0B25-4B2A-BCF4-4CD43675CA9A</gtr:id><gtr:title>Defining the Microglia Response during the Time Course of Chronic Neurodegeneration.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b4178e0339828a0d99625de1312863a"><gtr:id>0b4178e0339828a0d99625de1312863a</gtr:id><gtr:otherNames>Vincenti JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>58c2b02390f166.28921949</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/I001107/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>